There are 210 resources available
489 - Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
Presenter: Martin Reck
Session: Proffered Paper session I
Resources:
Abstract
Slides
Webcast
304 - T cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma
Presenter: Patrizia Comoli
Session: Proffered Paper session II
Resources:
Abstract
Slides
Webcast
277 - Successful use of interferon-alpha and adoptive T cell therapy for metastatic melanoma patients failing other treatment options
Presenter: Monique van der Kooij
Session: Proffered Paper session II
Resources:
Abstract
320 - Ligand-inducible, prostate stem cell antigen (PSCA)-directed GoCAR-T™ cells in advanced solid tumors: Preliminary results from a dose escalation study
Presenter: Carlos Becerra
Session: Proffered Paper session II
Resources:
Abstract
Slides
Webcast
286 - A small molecule human PD-1/PD-L1 inhibitor promotes T cell immune activation and reduces tumor growth in a preclinical model
Presenter: Marta Vilalta Colomer
Session: Proffered Paper session II
Resources:
Abstract
Handling of GI toxicity from immune checkpoint inhibitors
Presenter: Franck Carbonnel
Session: Management of side effects
Resources:
Slides
Webcast
Genetic host factors predictive of toxicity from immune checkpoint inhibitors
Presenter: Tomas Kirchhoff
Session: Management of side effects
Requirements for safely administering combination of ipilimumab + nivolumab
Presenter: Harriet Kluger
Session: Management of side effects
How rare are rare immune related Aes?
Presenter: Reinhard Dummer
Session: Management of side effects
Resources:
Slides
Webcast
Proffered Paper session II - Invited Discussant 31O, 32O and 68O
Presenter: George Coukos
Session: Proffered Paper session II
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.